The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study
Open accessAbstract
Abstract Importance Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes coronavirus disease 2019 (Covid-19), an evolving pandemic. Limited data are available characterizing SARS-Cov-2 infection in the United States. Objective To determine associations between demographic and clinical factors and testing positive for coronavirus 2019 (Covid-19+), and among Covid-19+ subsequent hospitalization and intensive care. Design, Setting, and Participants Retrospective cohort study including all patients tested for Covid-19 between February 8 and March 30, 2020, inclusive. We extracted electronic health record data from the national Veterans Affairs Healthcare System, the largest integrated healthcare system in the United States, on 2,026,227 patients born between 1945 and 1965 and active in care. Exposures Demographic data, comorbidities, medication history, substance use, vital signs, and laboratory measures. Laboratory tests were analyzed first individually and then grouped into a validated summary measure of physiologic injury (VACS Index). Main Outcomes and Measures We evaluated which factors were associated with Covid-19+ among all who tested. Among Covid-19+ we identified factors associated with hospitalization or intensive care. We identified independent associations using multivariable and conditional multivariable logistic regression with multiple imputation of missing values. Results Among Veterans aged 54-75 years, 585/3,789 (15.4%) tested Covid-19+. In adjusted analysis (C-statistic=0.806) black race was associated with Covid-19+ (OR 4.68, 95% CI 3.79-5.78) and the association remained in analyses conditional on site (OR 2.56, 95% CI 1.89-3.46). In adjusted models, laboratory abnormalities (especially fibrosis-4 score [FIB-4] >3.25 OR 8.73, 95% CI 4.11-18.56), and VACS Index (per 5-point increase OR 1.62, 95% CI 1.43-1.84) were strongly associated with hospitalization. Associations were similar for intensive care. Although significant in unadjusted analyses, associations with comorbid conditions and medications were substantially reduced and, in most cases, no longer significant after adjustment. Conclusions and Relevance Black race was strongly associated with Covid-19+, but not with hospitalization or intensive care. Among Covid-19+, risk of hospitalization and intensive care may be better characterized by laboratory measures and vital signs than by comorbid conditions or prior medication exposure. Key Points Question What are the demographic and clinical characteristics associated with testing positive for coronavirus 2019 (Covid-19+), and among Covid-19+ subsequent hospitalization and intensive care among Veterans in the United States? Findings In this retrospective cohort study of 2,026,227 Veterans aged 54-75 years and active in care, 585/3,789 (15.4%) tested Covid-19+. Black race was strongly associated with Covid-19+, but not with hospitalization or intensive care. Among Covid-19+, laboratory abnormalities and a summary measure of physiologic injury were strongly associated with hospitalization and intensive care. Meaning Racial differences in testing positive for Covid-19 may be an underestimate of the general population as racial health disparities in the Veterans Affairs Healthcare System tend to be smaller than in the private sector. Risk of hospitalization and intensive care may be better characterized by laboratory measures and vital signs than by comorbid conditions or prior medication exposure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674 · cited 2×
“To our knowledge, the largest medical record study to date analyzed COVID-19-related mortality in a population of 17 million residents in the UK, the vast majority of whom never tested for COVID-19 [26].”
BackgroundSelf-citationSohrabi, C., Alsafi, Z., O'Neill, N., Khan, M., Kerwan, A., Al-Jabir, A., Iosifidis, C., & Agha, R. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2020.02.034 · Cited by 6,069
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., et al. (2020) · JAMA · doi:10.1001/jama.2020.5394 · Cited by 5,469
Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Correa, M. C., Montaner, J., S. Sulkowski, M., Torriani, F. J., Dieterich, D. T., Thomas, D. L., et al. (2006) · Hepatology · doi:10.1002/hep.21178 · Cited by 5,021
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.017 · Cited by 4,206
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Fang, L., Karakiulakis, G., & Roth, M. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30116-8 · Cited by 2,911
Cited by
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674
Self-citationCOVID-19 and Racial/Ethnic Disparities
Webb Hooper, M., Nápoles, A. M., & Pérez-Stable, E. J. (2020) · JAMA · doi:10.1001/jama.2020.8598 · Cited by 2,047
Mackey, K., Ayers, C. K., Kondo, K. K., Saha, S., Advani, S. M., Young, S., Spencer, H., Rusek, M., Anderson, J., Veazie, S., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m20-6306 · Cited by 1,076
Magesh, S., John, D., Li, W. T., Li, Y., Mattingly-app, A., Jain, S., Chang, E. Y., & Ongkeko, W. M. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.34147 · Cited by 780
Izcovich, A., Ragusa, M. A., Tortosa, F., Lavena Marzio, M. A., Agnoletti, C., Bengolea, A., Ceirano, A., Espinosa, F., Saavedra, E., Sanguine, V., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0241955 · Cited by 660
Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis
Sze, S., Pan, D., Nevill, C. R., Gray, L. J., Martin, C. A., Nazareth, J., Minhas, J. S., Divall, P., Khunti, K., Abrams, K. R., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100630 · Cited by 633
Struyf, T., Deeks, J. J., Dinnes, J., Takwoingi, Y., Davenport, C., Leeflang, M. M., Spijker, R., Hooft, L., Emperador, D., Dittrich, S., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013665 · Cited by 571
A systematic review of racial/ethnic and socioeconomic disparities in COVID-19
Khanijahani, A., Iezadi, S., Gholipour, K., Azami-Aghdash, S., & Naghibi, D. (2021) · International Journal for Equity in Health · doi:10.1186/s12939-021-01582-4 · Cited by 556
Mathur, R., Rentsch, C. T., Morton, C. E., Hulme, W. J., Schultze, A., MacKenna, B., Eggo, R. M., Bhaskaran, K., Wong, A. Y. S., Williamson, E. J., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00634-6 · Cited by 501
Self-citationIs ethnicity linked to incidence or outcomes of covid-19?
Khunti, K., Singh, A. K., Pareek, M., & Hanif, W. (2020) · BMJ · doi:10.1136/bmj.m1548 · Cited by 493
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19
Rosenthal, N., Cao, Z., Gundrum, J., Sianis, J., & Safo, S. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.29058 · Cited by 484
COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State
Tesoriero, J. M., Swain, C.-A. E., Pierce, J. L., Zamboni, L., Wu, M., Holtgrave, D. R., Gonzalez, C. J., Udo, T., Morne, J. E., Hart-Malloy, R., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.37069 · Cited by 391
Romero Starke, K., Reissig, D., Petereit-Haack, G., Schmauder, S., Nienhaus, A., & Seidler, A. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-006434 · Cited by 373
Simons, D., Shahab, L., Brown, J., & Perski, O. (2021) · Addiction · doi:10.1111/add.15276 · Cited by 371
Garvin, M. R., Alvarez, C., Miller, J. I., Prates, E. T., Walker, A. M., Amos, B. K., Mast, A. E., Justice, A., Aronow, B., & Jacobson, D. (2020) · eLife · doi:10.7554/elife.59177 · Cited by 361
Self-citationIoannou, G. N., Locke, E., Green, P., Berry, K., O’Hare, A. M., Shah, J. A., Crothers, K., Eastment, M. C., Dominitz, J. A., & Fan, V. S. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.22310 · Cited by 354
Self-citationSARS-CoV-2 antibody prevalence in England following the first peak of the pandemic
Ward, H., Atchison, C., Whitaker, M., Ainslie, K. E. C., Elliott, J., Okell, L., Redd, R., Ashby, D., Donnelly, C. A., Barclay, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21237-w · Cited by 337
Leung, J. M., Niikura, M., Yang, C. W. T., & Sin, D. D. (2020) · European Respiratory Journal · doi:10.1183/13993003.02108-2020 · Cited by 287
Risk Factors for Severe COVID-19 in Children
Graff, K., Smith, C., Silveira, L., Jung, S., Curran-Hays, S., Jarjour, J., Carpenter, L., Pickard, K., Mattiucci, M., Fresia, J., et al. (2021) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003043 · Cited by 278
Romano, S. D., Blackstock, A. J., Taylor, E. V., El Burai Felix, S., Adjei, S., Singleton, C.-M., Fuld, J., Bruce, B. B., & Boehmer, T. K. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7015e2 · Cited by 273
Mude, W., Oguoma, V. M., Nyanhanda, T., Mwanri, L., & Njue, C. (2021) · Journal of Global Health · doi:10.7189/jogh.11.05015 · Cited by 262
Gu, T., Mack, J. A., Salvatore, M., Prabhu Sankar, S., Valley, T. S., Singh, K., Nallamothu, B. K., Kheterpal, S., Lisabeth, L., Fritsche, L. G., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.25197 · Cited by 260
Bilal, U., Tabb, L. P., Barber, S., & Diez Roux, A. V. (2021) · Annals of Internal Medicine · doi:10.7326/m20-3936 · Cited by 183
“However, 2 recent studies using data fromMichigan and the Veterans Affairs health system suggest that inequities in mortality are driven by differences in infection rates rather than differential vulnerability (45, 46).”
ResultRoutine laboratory testing to determine if a patient has COVID-19
Stegeman, I., Ochodo, E. A., Guleid, F., Holtman, G. A., Yang, B., Davenport, C., Deeks, J. J., Dinnes, J., Dittrich, S., Emperador, D., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013787 · Cited by 76
Gates, M., Pillay, J., Wingert, A., Guitard, S., Rahman, S., Zakher, B., Gates, A., & Hartling, L. (2021) · doi:10.1101/2021.04.23.21256014 · Cited by 5
Metadata
- Authors
- Rentsch, C. T., Kidwai-Khan, F., Tate, J. P., Park, L. S., King, J. T., Skanderson, M., Hauser, R. G., Schultze, A., Jarvis, C. I., Holodniy, M., Lo Re, V., Akgün, K. M., Crothers, K., Taddei, T. H., Freiberg, M. S., & Justice, A. C.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-09-22
- Volume
- 17
- Issue
- 9
- Pages
- e1003379
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W3087755171
- Cited by
- 526
- References
- 43
- FWCI
- 14.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.